Dr. Anastasia Zekeridou is a renowned expert in paraneoplastic neurologic disorders and a senior associate consultant at Mayo Clinic. In this discussion, she emphasizes the importance of collaboration between neurologists and oncologists for effective patient management. The conversation navigates the complexities of diagnosing paraneoplastic disorders and sheds light on the impact of cancer therapies on neurologic autoimmunity. Dr. Zekeridou also shares her journey through neurology and oncology, illustrating her dedication to this vital field.

In this fascinating discussion, distinguished immunologist Prof. Kingston Mills and neurological autoimmunity expert Dr. Anastasia Zekeridou dive deep into the powerful cytokine IL-17. They unpack its dual role in diseases like multiple sclerosis, emphasizing targeted therapies and potential risks of blocking IL-17. The guests also touch on the role of tissue-resident memory T cells and the implications of immune responses in paraneoplastic neurological syndromes. Their insights on antibody pathogenicity and the intersection of cancer treatment with neurological autoimmunity are truly enlightening.